1610m, 1600s, 1509s, 1468m, 1450m, 1432m, 1375s, 1292s; δH(300 MHz,
CDCl3) 7.34 (2 H, d, J 9.0), 6.8 (2 H, d, J 9.0), 4.74 (2 H, s), 3.77 (3 H,
s), 2.16 (2 H, d, J 14.1), 1.94 (1 H, d, J 13.2), 1.84 (1 H, s), 1.32–1.23 (12
H); δC(75 MHz, CDCl3) 176.56, 158.53, 130.55, 129.44, 113.53, 88.61,
69.43, 55.22, 48.07, 43.03, 42.86, 40.33, 33.17, 30.32, 26.1; HR-FT-
MALDI-MS (DHB) calcd for C21H25NO3Naϩ ([M ϩ Na]ϩ): 362.1727;
found: 326.1726; EA calcd for C21H25NO3 (339.43): C 74.31, H 7.42, N
4.13; found: C 74.34; H 7.62, N 4.04%. Preparation of 13: Alkyne 8
(0.63 g, 1.85 mmol) and 3-bromoquinoline (0.25 ml, 1.83 mmol) were
added to a pressure-resistant Schlenk flask, previously dried and evacu-
ated by N2-pump cycles. THF (15 ml) was added, the solution degassed
by three freeze–pump–thaw cycles and [Pd(PPh3)2Cl2] (64.4 mg,
c = 17.8082(7) Å, α = 88.088(3)Њ, β = 81.177(3)Њ, γ = 77.664(2)Њ, V =
2207.8(2) Å3, T = 100 K, Z = 2, µ = 0.170 mmϪ1, 6757 reflections
collected, R1 = 0.0843 based on F[I > 2σ(I )], wR(F 2) = 0.2353 (all data).
suppdata/ob/b4/b404311a/ for crystallographic data in .cif or other
electronic format.
1 (a) J. Rebek Jr., J. Mol. Recognit., 1988, 1, 1–8; (b) J. Rebek Jr.,
Angew. Chem., Int. Ed. Engl., 1990, 3, 245–255.
2 (a) G. S. Jeffrey, D. P. Curran, S. V. Geib, J. Rebek Jr. and P. Ballester,
J. Am. Chem. Soc., 1992, 114, 7007–7018; (b) K. S. Jeong, K. Parris,
P. Ballester and J. Rebek Jr., Angew. Chem., Int. Ed. Engl., 1990, 5,
555–556.
i
5 mol%), CuI (35 mg, 10 mol%) and Pr2NH (5 ml) were added under
N2. The mixture was degassed by four freeze–pump–thaw cycles and
stirred at 50 ЊC for 18 h. Upon cooling to r.t., Et2O was added and the
ammonium salt precipitated. The solution was filtered and concen-
trated to dryness. FC (SiO2; CH2Cl2/Et2O 10 : 0.1) afforded 13 (0.64 g,
75%) as a white solid, mp 146–147 ЊC; νmax(neat)/cmϪ1 2969w, 2933w,
1717w, 1667s, 1608w, 1513s, 1462w, 1378w, 1294m, 1250s, 1162s;
δH(300 MHz, CDCl3) 8.84 (1 H, d, J 1.8), 8.16 (1 H, d, J 1.8), 8.06 (1 H,
d, J 8.4), 7.74 (1 H, d, J 8.1), 7.66 (1 H, ddd, J 8.4, 7.8, 1.2), 7.51 (1 H,
td, J 8.1, 7.8), 7.14 (2 H, d, J 8.4), 6.72 (2 H, d, J 8.4), 4.64 (2 H, s), 3.70
(3 H, s), 2.31 (2 H, d, J 12.6), 1.92 (1 H, d, J 13.5), 1.40–1.24 (12 H, m);
δC(75 MHz, CDCl3) 177.04, 165.40, 158.85, 152.41, 146.91, 138.61,
130.31, 130.14, 130.00, 129.58, 127.78, 127.44, 117.37, 113.85, 97.78,
55.38, 48.24, 43.09, 42.96, 40.59, 33.37, 31.56, 26.30; HR-FT-MALDI-
3 A. Yanagisawa, T. Kikuchi, T. Watanabe, T. Kuribayashi and
H. Yamamoto, Synlett, 1995, 372–374.
4 (a) T. Bach, Synlett, 2000, 12, 1699–1707; (b) T. Bach, H. Bergmann
and K. Harms, Angew. Chem., Int. Ed., 2000, 13, 2302–2304.
5 (a) J. Rebek Jr., K. Williams, K. Parris, P. Ballester and K. S. Jeong,
Angew. Chem., Int. Ed. Engl., 1987, 26, 1244–1245; (b) K. Williams,
B. Askew, P. Ballester, C. Buhr, K. S. Jeong, S. Jones and J. Rebek Jr.,
J. Am. Chem. Soc., 1989, 111, 1090–1094.
6 (a) R. K. Castellano, V. Gramlich and F. Diederich, Chem. Eur. J.,
2002, 8, 118–129; (b) R. Faraoni, R. K. Castellano, V. Gramlich and
F. Diederich, Chem. Commun., 2004, 370–371.
7 (a) S. Müller, B. Liepold, G. J. Roth and H. J. Bestmann, Synlett,
1996, 521–522; (b) for the preparation of the diazophosphonate 12,
see P. Callant, L. D’Haenens and M. Vandewalle, Synth. Commun.,
1984, 14, 155–161.
8 A. P. Bisson, C. A. Hunter, J. C. Morales and K. Young, Chem. Eur.
J., 1998, 4, 845–851.
ϩ
MS (DHB) calcd for C30H31N2O3 (MHϩ): 467.2329; found: 467.2326;
EA calcd for C30H30N2O3 (466.58): C 77.23, H 6.48, N 6.00; found: C
76.94; H 6.65, N 5.99%.
§ Crystal data. Compound 6, C22H22N2O2, M = 346.43, monoclinic,
space group P21/a, a = 14.9171(2), b = 12.9531(2), c = 19.9159(3) Å, β =
107.7345(8)Њ, V = 3665.33(9) Å3, T = 172 K, Z = 8, µ = 0.081 mmϪ1
,
9 The imide–adenine H-bonding contribution has been extrapolated
from the complexation behaviour of dihydrouracil derivatives with
adenine in CDCl3, see: Y. Kyogoku, R. C. Lord and A. Rich, Nature,
1968, 218, 69–72.
9409 reflections collected, R1 = 0.0485 based on F [I > 2σ(I )], wR(F 2) =
0.1541 (all data). Compound 7, 2(C21H26N16O2)ؒ0.5(CHCl3), M =
¯
848.13, triclinic, space group P1, a = 7.6166(3), b = 16.8616(8),
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2, 1 9 6 2 – 1 9 6 4
1964